Studies about Cetyl Myristoleate
Cetyl myristoleate, CM or CMO, is one of the substances claimed to be extremely helpful for people suffering from arthritis. There are several scientific studies that can confirm what some arthritis patients already experienced as positive results of the Cetyl Myristoleate treatment.
The first study with Cetyl Myristoleate on human subjects was completed in 1995. This San Diego study showed very good results and almost all patients (46 out of the 48 involved in the study) experienced good results with this substance. Patients reported that the pain has subsided and more than 70% of them felt less painful sensations after the use of this medication. Also, 80% of the patients have noticed significant improvement in the mobility. This study has some downfalls, when it comes to the number of participants and the lack of control group of patients, but it was the good starting point for some further research about Cetyl Myristoleate and the effects on people suffering from arthritis.
In 1997, there was another study with the similar subject. There were much more patients involved (431) and patients received placebo, Cetyl Myristoleate or combination of CM, glucosamine, hydrolyzed cartilage and sea cucumber. The improvement was seen in over 60% of patients using Cetyl Myristoleate or CM plus additional substances.
Additional studies involved patients suffering from chronic knee osteoarthritis (OA) and using CM to treat their condition. The results showed significant improvement in knee range motion and some other physical capabilities of these patients. Because of that scientists even pronounced CM to be the alternative to non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of osteoarthritis.
Scientists continued the studies about Cetyl Myristoleate and its use in patients diagnosed with arthritis. One of the most recent researches included a large number of patients suffering from this problem and about some 1800 patients were involved in the study. After the course of 16 days of using Cetyl Myristoleate, more than 85% of all patients have showed at least 50% recovery.
Results of the CM in Arthritis Patients
There is an increasing amount of information supporting the claim that Cetyl Myristoleate is efficient as the treatment for arthritis. The costs of commonly prescribed treatment for arthritis usually are very high and, furthermore, many people die every year because of the NSAIDs used in this treatment. CM is much less expensive than the conventional treatments and although the information provided so far is not yet conclusive, CM products can be considered at least as a treatment worth of research.